# Diagnostic Value of sFlt-1/PlGF Ratio for the Etiology of Intra Uterine Growth Restriction - ANGIOPAG

> **NCT05151289** · NA · UNKNOWN · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 152 (estimated)

## Conditions studied

- Intrauterine Growth Restriction
- Fetal Growth Restriction (FGR)

## Interventions

- **BIOLOGICAL:** Blood test at time of inclusion for sFlt-1/PlGF ratio
- **BIOLOGICAL:** Follow-up blood test 2 to 4 weeks after inclusion
- **DIAGNOSTIC_TEST:** Placenta analysis for all included patients, even in case of normal birthweight

## Key facts

- **NCT ID:** NCT05151289
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-01-08
- **Primary completion:** 2022-01-29
- **Final completion:** 2022-01-29
- **Target enrollment:** 152 (ESTIMATED)
- **Last updated:** 2021-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05151289

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05151289, "Diagnostic Value of sFlt-1/PlGF Ratio for the Etiology of Intra Uterine Growth Restriction - ANGIOPAG". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT05151289. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*